4 employees
Potenza Therapeutics is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs.
2014
$30M
from 2 investors over 2 rounds
POTENZA Therapeutics raised $30M on March 17, 2016
Investors: InterWest Partners and MPM Capital